Background: Vaspin is a visceral adipose tissue-derived serine protease inhibitor that has an insulin-sensitizing effect. It is correlated with insulin resistance and glucose metabolism, and it improves glucose tolerance. Aim: The aim of this study was to determine and compare serum vaspin and insulin concentrations in small-forgestational age (SGA), appropriate-for-gestational age (AGA), and large-for-gestational age (LGA) infants at birth and fi fth postnatal day. Patients and methods: Eighty-two neonates were divided into three groups: SGA (n = 22), AGA (n = 30), and LGA (n = 30). Mothers ' age, gestational week, mode of delivery, and maternal diseases, such as diabetes, pre-eclampsia, and eclampsia were recorded. Blood for vaspin, insulin, and glucose was collected from the cord at birth and from a peripheral vein on the fi fth postnatal day. Results: At birth, there were no statistically signifi cant difference in serum insulin concentrations among the three groups, whereas cord serum vaspin concentrations were signifi cantly higher in the SGA group ( χ 2 = 8.158, p < 0.05). Serum glucose and vaspin levels on the fi fth postnatal day had no signifi cant difference among three groups (p < 0.05). Circulating vaspin concentrations were not associated with the sex of the infant and delivery route. Conclusion: Cord vaspin levels are signifi cantly higher in SGA neonates than in AGA or LGA neonates. The fetal programming hypothesis proposes that many adulthood diseases originate from the adaptation that the fetus makes when it is
Introduction
Adipose tissue secretes a number of hormones called adipocytokines, which are mediators of insulin resistance (1, 2) . As most of the adipocytokines are produced during intrauterine life, they have a role in fetal growth (3, 4) . One of the newly identifi ed hormones, vaspin, is a visceral adipose tissuederived serine protease inhibitor that has an insulin-sensitizing effect (5) . It has been shown that vaspin is correlated with insulin resistance and glucose metabolism and improves glucose tolerance (5, 6) . Elevated serum vaspin concentrations and lower adiponectin levels have been shown in obese children, and these adipokines were signifi cantly correlated with insulin sensitivity indices (7) . Caminos et al. (8) reported that vaspin was present in both human and rat placenta, that food restriction had contrary effects on its expression, and that vaspin regulated placental metabolic functions.
The thrifty phenotype hypothesis proposes that there is an evidence of associations between poor fetal and infant growth and the consequent development of type 2 diabetes and the metabolic syndrome (9) . As there was no information about circulating vaspin concentrations during perinatal period, Briana et al. (10) compared the vaspin and insulin concentrations in intrauterine growth-restricted (IUGR) and appropriate-for-gestational age (AGA) neonates and their mothers. They reported that vaspin concentrations were similar in IUGR and AGA cases, but insulin concentrations were lower in IUGR neonates. In 2011, Cekmez et al. (11) studied the vaspin levels in large-for-gestational age (LGA) and AGA neonates and reported that vaspin levels were insignifi cantly higher in LGA neonates.
To the best of our knowledge, this is the fi rst study to determine and compare serum vaspin concentrations with insulin in small-for-gestational age (SGA), AGA, and LGA infants at birth (from cord blood) and on the fi fth postnatal day.
Patients and methods
This study was conducted between January and December 2010 in our maternity service. A total of 82 neonates (39 girls and 43 boys) were enrolled in the study. Approval for the study was obtained from the local Ethics Committee, and informed consent was obtained from the parents. Subjects were divided into three groups using the Fenton intrauterine growth curves (12) : SGA, AGA, and LGA. The SGA group represents babies with birth weight lower than the 10th percentile; AGA, between the 10th and the 90th percentiles; LGA, higher than the 90th percentile of Fenton ' s intrauterine growth curve, and these groups consisted of 22, 30, and 30 patients, respectively.
Mothers ' age, gestational week, mode of delivery, and maternal diseases, such as diabetes, pre-eclampsia, and eclampsia were recorded. All of the neonates were healthy, had normal physical examination, with Apgar scores at 5 min > 8, and had no congenital anomalies, intrauterine or systemic infections, or conditions needing intensive care. Pregnancy is considered at term when gestation attains 37 complete weeks. None of the mothers had a history of smoking during the pregnancy. In the LGA group, three mothers had a history of gestational diabetes and six gained > 20 kg during the pregnancy. In the AGA group, two mothers had a history of gestational diabetes, and in the SGA group, three mothers had pre-eclampsia and four mothers gained < 7 kg during the pregnancy. Anthropometric measurements (height, weight, and head circumference) were done immediately after birth by the delivery room nurse.
Blood samples
Blood was collected from the cord soon after birth and from a peripheral vein on the fi fth postnatal day. Serum insulin concentrations were determined simultaneously. After clotting, the blood serum for vaspin was centrifuged, separated, and stored at -80 ° C until analyis. Plasma glucose was determined by standard biochemical methods. Plasma insulin levels were determined by chemiluminescence. Serum vaspin concentrations were analyzed by ELISA (Human Vaspin Biovendor, Brno, Czech Republic). Minimum detectable value was 0.01 ng/mL for vaspin and 0.5 mU/mL for insulin.
Statistical analysis
SPSS version 17 (SPSS Inc., Chicago, IL, USA) was used for the analysis. Data were expressed as mean ± SD. The KolmogorovSmirnov test was applied to check the normality of the variables. Differences in the means of variables were tested using both parametric and non-parametric tests depending on the distribution of the variables. Serum insulin and vaspin levels were analyzed by Mann-Whitney U-test and Kruskal-Wallis tests. Bonferroni correction made for the comparison of the three groups. Cord and fi fth-day concentrations were compared by Wilcoxon test. One-way ANOVA was used for normally distributed data. Correlation analyses were conducted using Spearman or Pearson correlation coeffi cients, depending on the distribution of the variables. Statistical signifi cance was taken as p < 0.05.
Results
The characteristics of the 82 neonates (SGA, n = 22; AGA, n = 30; LGA, n = 30) are summarized in Table 1 . None of the groups showed signifi cant differences in terms of mothers ' age, gestational weeks, and delivery route. Male newborns in the LGA group and female newborns in the SGA group were statistically higher compared with other groups. When we analyzed the association between sex and delivery route with serum vaspin concentrations, we found no statistically signifi cant difference.
Serum insulin and vaspin concentrations are shown in Table 2 . At birth, there was no statistically signifi cant difference in cord insulin and glucose concentrations among the three groups, whereas cord vaspin concentrations were signifi cantly higher in the SGA group ( χ 2 = 8.158, p < 0.05). When we analyzed the serum glucose, insulin, and vaspin levels on the fi fth postnatal day, we determined no signifi cant difference among the three groups (p < 0.05) (Figure 1 ).
There was no signifi cant difference between cord serum glucose and insulin concentrations at birth and on the fi fth postnatal day in the SGA group, but vaspin concentrations on the fi fth postnatal day were statistically signifi cantly higher than cord concentrations in the SGA group (p < 0.05).
In the AGA group, insulin concentration on the fi fth postnatal day was signifi cantly lower than birth, and glucose and vaspin concentrations were statistically higher on the fi fth postnatal day compared with cord levels (p < 0.05).
In the LGA group, insulin concentrations at birth and on the fi fth postnatal day were insignifi cant, but glucose and vaspin concentrations on the fi fth postnatal day were statistically signifi cantly higher than cord blood (p < 0.05).
In correlation analysis, a negative correlation between vaspin and insulin concentrations on the fi fth postnatal day (r = − 0.469, p < 0.05) was demonstrated in the LGA group.
Discussion
Vaspin is a newly described adipocytokine, which is predominantly secreted in visceral white adipose tissue. It has been reported that vaspin mRNA expression in visceral fat is positively correlated with the amount of body fat and that the administration of vaspin to obese mice improves glucose tolerance and insulin sensitivity and leads to reversal of altered expression of insulin resistance-relevant genes including leptin, adiponectin, resistin, and tumor necrosis factor α (5, 6) . However, in humans, the effect of vaspin on insulin sensitivity is not clear. The correlation between vaspin and body mass index is also uncertain (13, 14) . According to Briana et al. (10) , there is a positive correlation between maternal and fetal vaspin concentrations, suggesting their transplacental transport, but as their levels do not decline after birth, the adipose tissue of the newborn is probably the main source of these adipocytokines. Up to now, there are limited studies evaluating serum vaspin levels in SGA and AGA or LGA and AGA neonates (10, 11) . To the best of our knowledge, this is the fi rst study comparing the course of serum vaspin and insulin concentrations both at birth and on the fi fth postnatal day in all SGA, AGA, and LGA neonates. We demonstrated that cord vaspin levels were significantly higher in SGA neonates than AGA or LGA neonates. Mechanisms controlling intrauterine growth are not exactly clear. In IUGR infants, the total amount of fat mass is reduced, adipose tissue development is altered, and the infants may have relatively higher visceral fat stores (15 -18) . We suggest that the higher visceral fat stores may be the source of higher cord vaspin concentrations in SGA neonates in our study. We determined increasing levels of vaspin concentrations on the fi fth postnatal day in three groups, the difference was statistically insignifi cant on the fi fth postnatal day among the SGA, AGA, and LGA groups.
These results suggest that there may be other possible mechanisms that increase vaspin concentrations at cord blood rather than increase visceral fat tissue. Briana et al.
(10) evaluated the vaspin concentrations in both neonates and their mothers. A positive correlation was found, implying transplacental passage of vaspin, but they stated that, as their concentrations do not decline after birth, the placenta was not the exact source of these hormones. Also, it is known that vaspin has a 40 % -45 % similar structure to α 1-antitrypsin, and this structure is not suitable for placental transfer. We did not evaluate the maternal vaspin concentrations, and thus we could not compare the cord vaspin levels with them. This is the limitation of our study. Vaspin is involved in energy metabolism like other adipocytokines. The higher levels of vaspin at birth in SGA infants compared with AGA and LGA infants may be the result of its role in energy homeostasis in intrauterine life.
Vaspin concentrations did not differ between AGA and LGA infants in our study group at birth and on the fi fth postnatal day (p < 0.05). Similarly, Cekmez et al. (11) found no signifi cant difference in vaspin levels between LGA and AGA infants at birth. In our study, insulin levels at birth in LGA infants and on the fi fth day of SGA and AGA infants were similar. Insulin concentrations may be expected to be higher in LGA infants. Cekmez et al. detected higher insulin concentrations in cord blood of macrosomic infants of diabetic mothers compared with AGA infants and macrosomic infants whose mothers had no history of diabetes. In our study group, most of the mothers of the LGA infants were non-diabetic, except three.
There is no concensus about the relationship between vaspin and insulin resistance in the literature. Lee et al. (19) showed a negative correlation between vaspin and homeostasis model assessment for insulin resistance (HOMA-IR), whereas some other studies showed no association between serum vaspin and HOMA-IR (11, 20, 21) . In our study, we did not fi nd any correlation between cord vaspin and insulin in the combined group, but on fi fth postnatal day, there was a negativel correlation between vaspin and insulin (r = -0.258, p < 0.05). Similar to our study, Briana et al. (10) showed that vaspin concentrations did not correlate with insulin levels in maternal, fetal, and neonatal samples. In the LGA group, there was a negative correlation between vaspin and insulin concentrations on the fi fth postnatal day (r = -0.469, p < 0.05). Delivery route is suggested to affect the serum concentrations of vaspin. In a recent study, maternal vaspin concentrations were signifi cantly lower in cases of vaginal delivery (10) . As vaspin expression may be altered in infl ammatory states, infl ammation during spontaneous vaginal delivery may be the cause. In our study, we did not fi nd any association between delivery route and serum vaspin levels in infants.
Sex-dependent differences in adipose tissue distribution and mass may lead to increased vaspin concentrations in females (10, 13, 22) . Also, sex hormones secreted from the ovaries may be the cause of increased vaspin levels in female neonates. However, we could not demonstrate any association between sex and serum vaspin levels in our study.
In conclusion, our results demonstrated increased levels of vaspin concentrations in the cord blood of SGA neonates compared with AGA and LGA neonates. Based on our results, it is not possible to explain the relation between birth weight and the adipocytokine vaspin, but vaspin can be used as a predictor of metabolic syndrome in SGA neonates. In recent years, many actual studies emphasize fetal programming of adult diseases. Low birth weight was shown to be associated with markedly increased rates of cardiovascular disease and non-insulin-dependent diabetes in adult life (23) . The fetal programming hypothesis proposes that these diseases originate from the adaptation that the fetus makes when it is undernourished. High cord-vaspin levels in SGA infants may be one of the adaptations of fetal programming. Long-term follow-up of these infants through adulthood will shed light on this hypothesis.
